According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Intrexon CEO bought 2,096,209 shares
Intrexon Corp. (XON, Financial) CEO and 10% Owner Randal J. Kirk bought 2,096,209 shares during the past week at the average price of $4.40.
Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company has a market cap of $751.53 million. Its shares traded at $4.66 as of May 20.
Net loss for the first quarter of 2019 was $62 million compared to $47 million for the prior-year period.
Kirk bought 838,482 and 1,257,727 shares on May 15 at the average price of $4.4. The price of the stock has increased by 5.91% since.
Newmark Group CEO bought 562,284 shares
Newmark Group Inc. (NMRK, Financial) CEO Barry M. Gosin bought 562,284 shares during the past week at the average price of $7.71.
Newmark Group is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company has a market cap of $2.05 billion. Its shares traded at $8.43 with a price-earnings ratio of 14.69 as of May 20.
Net income available to common stockholders for the first quarter of 2019 was $16.90 million compared to $20.0 million for the comparable period of 2018.
Gosin bought 561,084 shares on May 14 at a price of $7.71 and 1,200 shares on May 15 at a price of $7.98. The price of the stock has increased by 5.64% since.
Continental Resources CEO bought 93,000 shares
Continental Resources Inc. (CLR, Financial) CEO, Chairman and 10% Owner Harold Hamm bought 93,000 shares on May 16 at a price of $42.71. The price of the stock has decreased by 2.48% since.
Continental Resources is a U.S. oil and gas producer targeting in the Bakken Shale in North Dakota, and the Scoop/Stack plays in Oklahoma. At the end of 2017, the company reported net proved reserves of 1.3 billion barrels of oil equivalent. Net production averaged 243 thousand barrels of oil equivalent per day in 2017, at a ratio of 57% oil and 43% natural gas and NGLs. The company has a market cap of $15.54 billion. Its shares traded at $41.65 with a price-earnings ratio of 16.59 as of May 20.
Net income for the first quarter of 2019 was $187 million compared to $234 million for the prior-year period.
Qurate Retail CEO bought 244,568 shares
Qurate Retail Inc. (QRTEA, Financial) President and CEO Michael A. George bought 244,568 shares on May 13 at a price of $12.51. The price of the stock has increased by 7.91% since.
Qurate Retail, formerly Liberty Interactive, is a conglomerate comprised of seven leading retail brands: QVC, HSN, zulily, Ballard Designs, Frontgate, Garnet Hill and GrandinRoad. The company has a market cap of $5.80 billion. Its shares traded at $13.50 with a price-earnings ratio of 10.43 as of May 20.
Net income for the first quarter of 2019 was $55 million compared to $142 million for the prior-year period.
Chairman of the Board Gregory B. Maffei bought 100,000 shares on May 14 at a price of $12.49 and 50,000 shares on May 15 at a price of $12.75. The price of the stock has increased by 5.88% since.
Director and 10% Owner John C. Malone bought 800,000 shares on May 13 at a price of $12.48. The price of the stock has increased by 8.17% since.
OPKO Health CEO bought 1,350,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% Owner Phillip Frost bought 1,350,000 shares during the past week at the average price of $2.00.
OPKO Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. The company’s diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. OPKO Health also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. The company has a market cap of $1.23 billion. Its shares traded at $1.99 as of May 20.
Net loss for the first quarter of 2019 was $80.8 million compared with a net loss of $43.1 million for the comparable period of 2018.
Frost bought 70,000 shares on May 10 at a price of $2.08; 200,000 shares on May 13 at a price of $1.99; 1,000,000 shares on May 14 at a price of $2; 100,000 shares on May 16 at a price of $2.02; and 50,000 shares on May 17 at a price of $2.08. The price of the stock has decreased by 4.33% since.
Senior Vice President and Chief Financial Officer Adam Logal bought 3,250 shares on May 9 at a price of $2.04. The price of the stock has decreased by 2.45% since.
Director Richard C. Pfenniger Jr. bought 50,000 shares on May 13 at a price of $2.05. The price of the stock has decreased by 2.93% since.
Vice Chairman and Chief Technical Officer Jane Hsiao bought 10,000 shares on May 9 at a price of $2.03. The price of the stock has decreased by 1.97% since.
Executive Vice President of Administration Steven D. Rubin bought 10,000 shares on May 9 at a price of $2.14. The price of the stock has decreased by 7.01% since.
Director John A. Paganelli bought 10,000 shares on May 9 at a price of $2.09. The price of the stock has decreased by 4.78% since.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned.
Read more here:Â
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Â
